Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Complex Regional Pain Syndromes | 5 | 2022 | 11 | 1.880 |
Why?
|
| Cytokines | 3 | 2022 | 1401 | 1.090 |
Why?
|
| Fibromyalgia | 3 | 2017 | 21 | 0.700 |
Why?
|
| Stress, Psychological | 3 | 2015 | 603 | 0.550 |
Why?
|
| Low Back Pain | 3 | 2013 | 40 | 0.540 |
Why?
|
| Anxiety | 3 | 2015 | 1000 | 0.510 |
Why?
|
| Facial Pain | 1 | 2015 | 8 | 0.500 |
Why?
|
| Pain Management | 2 | 2015 | 200 | 0.490 |
Why?
|
| Monitoring, Immunologic | 1 | 2015 | 17 | 0.490 |
Why?
|
| Statistics as Topic | 2 | 2015 | 261 | 0.480 |
Why?
|
| Persian Gulf Syndrome | 1 | 2015 | 16 | 0.480 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 80 | 0.430 |
Why?
|
| Immunoassay | 1 | 2013 | 139 | 0.410 |
Why?
|
| Specimen Handling | 1 | 2013 | 148 | 0.400 |
Why?
|
| Depression | 3 | 2015 | 1363 | 0.380 |
Why?
|
| Patient Care Team | 1 | 2015 | 574 | 0.360 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 259 | 0.360 |
Why?
|
| Pain | 4 | 2022 | 476 | 0.350 |
Why?
|
| Affect | 1 | 2011 | 172 | 0.340 |
Why?
|
| Whiplash Injuries | 1 | 2010 | 3 | 0.330 |
Why?
|
| Hypesthesia | 1 | 2010 | 11 | 0.330 |
Why?
|
| Neck Pain | 1 | 2010 | 19 | 0.330 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 152 | 0.310 |
Why?
|
| Chronic Pain | 3 | 2018 | 149 | 0.300 |
Why?
|
| Wrist Injuries | 2 | 2018 | 7 | 0.270 |
Why?
|
| Brain | 2 | 2021 | 3224 | 0.270 |
Why?
|
| Depressive Disorder | 1 | 2010 | 484 | 0.250 |
Why?
|
| Pain Measurement | 4 | 2015 | 370 | 0.250 |
Why?
|
| Quality of Life | 1 | 2014 | 2160 | 0.220 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 3114 | 0.220 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2023 | 13 | 0.210 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 14 | 0.200 |
Why?
|
| Radiation Protection | 1 | 2022 | 57 | 0.190 |
Why?
|
| Neurogenesis | 2 | 2021 | 223 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2022 | 3668 | 0.190 |
Why?
|
| Radiation Exposure | 1 | 2022 | 49 | 0.180 |
Why?
|
| Antigens, Differentiation | 1 | 2021 | 69 | 0.180 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2021 | 65 | 0.170 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 433 | 0.170 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 58 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 284 | 0.160 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2019 | 12 | 0.160 |
Why?
|
| Neutrophil Activation | 1 | 2019 | 15 | 0.160 |
Why?
|
| Chronic Disease | 4 | 2011 | 1250 | 0.160 |
Why?
|
| Space Flight | 1 | 2022 | 169 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 48 | 0.150 |
Why?
|
| Hand Bones | 1 | 2018 | 2 | 0.150 |
Why?
|
| Humans | 20 | 2023 | 134156 | 0.150 |
Why?
|
| Neutrophils | 1 | 2019 | 402 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2018 | 211 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 535 | 0.120 |
Why?
|
| Hand Injuries | 1 | 2015 | 17 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2022 | 6601 | 0.120 |
Why?
|
| Cerebellum | 1 | 2019 | 467 | 0.120 |
Why?
|
| Progesterone | 1 | 2017 | 635 | 0.120 |
Why?
|
| Young Adult | 5 | 2017 | 9944 | 0.120 |
Why?
|
| Hippocampus | 1 | 2021 | 863 | 0.120 |
Why?
|
| Demography | 1 | 2015 | 247 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 1167 | 0.110 |
Why?
|
| Middle Aged | 8 | 2018 | 29399 | 0.110 |
Why?
|
| Analgesics | 1 | 2015 | 133 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2022 | 5222 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2013 | 3999 | 0.110 |
Why?
|
| Chemokine CCL4 | 1 | 2013 | 14 | 0.110 |
Why?
|
| Physical Therapy Specialty | 1 | 2013 | 5 | 0.110 |
Why?
|
| Freezing | 1 | 2013 | 29 | 0.110 |
Why?
|
| Naltrexone | 1 | 2014 | 70 | 0.110 |
Why?
|
| Logistic Models | 1 | 2018 | 1909 | 0.100 |
Why?
|
| Blister | 1 | 2013 | 22 | 0.100 |
Why?
|
| Somatosensory Cortex | 1 | 2013 | 57 | 0.100 |
Why?
|
| Motor Cortex | 1 | 2013 | 85 | 0.100 |
Why?
|
| Acute Pain | 1 | 2013 | 17 | 0.100 |
Why?
|
| Self Efficacy | 1 | 2013 | 207 | 0.100 |
Why?
|
| Male | 9 | 2018 | 66127 | 0.090 |
Why?
|
| Testosterone | 1 | 2017 | 623 | 0.090 |
Why?
|
| Female | 9 | 2018 | 71928 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 316 | 0.090 |
Why?
|
| Pain Clinics | 1 | 2010 | 4 | 0.090 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 51 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2011 | 145 | 0.090 |
Why?
|
| Adult | 6 | 2018 | 31945 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 3043 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 288 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 469 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 482 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1987 | 152 | 0.060 |
Why?
|
| Australia | 2 | 2018 | 186 | 0.060 |
Why?
|
| Veterans | 1 | 2015 | 1785 | 0.050 |
Why?
|
| Aged | 4 | 2017 | 21775 | 0.050 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2023 | 8 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2015 | 195 | 0.050 |
Why?
|
| Hydrolases | 1 | 2023 | 61 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 174 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 20624 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 265 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 239 | 0.040 |
Why?
|
| Biology | 1 | 2021 | 29 | 0.040 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 55 | 0.040 |
Why?
|
| Autophagy | 1 | 2023 | 429 | 0.040 |
Why?
|
| Animals | 4 | 2022 | 36557 | 0.040 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 35 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 599 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 486 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 94 | 0.040 |
Why?
|
| Mice | 3 | 2021 | 19055 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2017 | 122 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 231 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 548 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2019 | 837 | 0.030 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 314 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 723 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2539 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2019 | 834 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 877 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1506 | 0.030 |
Why?
|
| Publication Bias | 1 | 2013 | 17 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 1306 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2015 | 505 | 0.020 |
Why?
|
| Neuroglia | 1 | 2014 | 215 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2010 | 44 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2010 | 23 | 0.020 |
Why?
|
| Proprioception | 1 | 2010 | 20 | 0.020 |
Why?
|
| Neurons | 1 | 2021 | 2050 | 0.020 |
Why?
|
| Outpatients | 1 | 2010 | 276 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 5086 | 0.020 |
Why?
|
| Glucose | 1 | 2013 | 927 | 0.020 |
Why?
|
| Health Status | 1 | 2010 | 412 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4808 | 0.020 |
Why?
|
| Patients' Rooms | 1 | 1987 | 9 | 0.020 |
Why?
|
| New Zealand | 1 | 1987 | 61 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 481 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1987 | 77 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 490 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2010 | 574 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3754 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4934 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 680 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3857 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 5477 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 17540 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 13074 | 0.010 |
Why?
|